Subclinical Keratoconus and Inflammatory Molecules from Tears
Overview
Authors
Affiliations
Background/aims: Tissue degradation in corneal thinning disorders, such as keratoconus (KC), involves the expression of inflammatory mediators. The purpose of this study was to determine the levels of proinflammatory cytokines and matrix metalloproteinase 9 (MMP-9) in tears from both eyes of unilateral keratoconus (KC) patients.
Methods: Thirty patients diagnosed as having asymmetrical KC (30 KC eyes, and 30 subclinical KC eyes) and 20 normal control subjects (one eye) were studied in a prospective, cross-sectional study. Keratoconus screening programmes were performed on these participants. Ten microlitres of tears was collected from each eye. The concentrations of cytokines (interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-alpha)) and MMP-9 were measured by ELISA.
Results: Mean values for IL-6 levels were similar in KC and subclinical KC samples (5.5 (4.9 to 6.9) vs 5.7 (4.5 to 6.2) pg/ml, p = 0.131), but significantly higher in relation to the control group (2.2 (1.0 to 4.1) pg/ml, p<0.0001). Significant differences were found in TNF-alpha levels between KC and subclinical KC eyes (5.4 (4.1 to 6.8) vs 4.8 (4.2 to 6.0) pg/ml, p = 0.032) and control group (1.8 (1.5 to 2.3) pg/ml, p<0.0001). Increased values of MMP-9 were found in KC (59.4 (50.6 to 66.1) ng/ml) vs subclinical KC eye (7.0 (4.8 to 8.6) ng/ml) (p<0.0001). MMP-9 levels in the control group (6.1 (3.9 to 8.3) ng/ml) and subclinical KC were similar (p = 0.203).
Conclusions: IL-6 and TNF-alpha are overexpressed in the tears of subclinical and KC eyes. Increased MMP-9 levels were found only in the KC eye. These results indicate that the pathogenesis of KC may involve chronic inflammatory events.
Kannan R, Shetty R, Panigrahi T, Koh S, Khamar P, Deshpande V Invest Ophthalmol Vis Sci. 2025; 66(2):60.
PMID: 39992672 PMC: 11878249. DOI: 10.1167/iovs.66.2.60.
Schliffka M, Siegel H, Auw-Haedrich C, van Oterendorp C, Boehringer D, Reinhard T J Clin Med. 2025; 14(2).
PMID: 39860466 PMC: 11765851. DOI: 10.3390/jcm14020461.
Demir S Eye Contact Lens. 2024; 51(3):e107-e111.
PMID: 39629721 PMC: 11850007. DOI: 10.1097/ICL.0000000000001158.
Santhiago M, Stival L, Araujo D, Antunes-Foschini R, Toledo M, Nunes I Ophthalmol Sci. 2024; 5(1):100624.
PMID: 39624797 PMC: 11609233. DOI: 10.1016/j.xops.2024.100624.
Increased inflammatory mediators in the ocular surface tissue in keratoconus.
Santos A, Filho J, Cenedeze M, Hiyane M, Amano M, Cruz M Mol Vis. 2024; 30:279-288.
PMID: 39563679 PMC: 11575844.